01.09.2024 - By American College of Cardiology
In this interview, Andrew Kates, MD, FACC, and Alison L. Bailey, MD, FACC, discuss the top takeaways in general cardiology from 2023 including ARAMIS, ORBITA-2, and STOP-CA trials. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL